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Abstract
The ATP/ADP translocase (Tlc) of Rickettsia prowazekii is a basic protein with isoelectric point (pI)=9.84. It is conceivable, therefore,
that basic residues in this protein are involved in electrostatic interactions with negatively charged substrates. We tested this hypothesis by
individually mutating all basic residues in Tlc to Cys. Unexpectedly, mutations of only 20 out of 51 basic residues resulted in greater than
80% inhibition of transport activity. Moreover, 12 of 51Cys-substitution mutants exhibited higher than wild-type (WT) activity. At least in
one case this up-effect was additive and the double mutant Lys422Cys Lys427Cys transported ATP five-fold better than WT protein. Since in
these two single mutants and in the corresponding double mutant Km’s were similar to that of WT protein, we conclude that Tlc may have
evolved a mechanism that limits the transporter’s exchange rate and that at least these two basic residues play a key role in that mechanism.
Based on the alignment of 16 Tlc homologs, the loss of activity in the mutants poorly correlates with charge conservation within the Tlc
family. Also, despite the presence of three positively charged and one negatively charged intramembrane residues, we have failed to identify
potential charge pairs (salt bridges) by either charge reversal or charge neutralization approaches.
D 2002 Published by Elsevier Science B.V.
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1. Introduction
The obligate intracellular bacterium Rickettsia prowaze-
kii, the aetiologic agent of epidemic typhus, grows and
multiplies only within the cytoplasm of a eucaryotic cell. As
an adaptation to this unusual ecological niche, R. prowazekii
evolved to possess transport systems that allow it to take
advantage of the many preformed metabolites that are
abundant in the host cell. The ATP/ADP translocase (Tlc)
that performs an exchange of ADP, generated as a result of
rickettsial metabolism, for the high-energy ATP of the host
cell, is an example of such system [1]. Although ancestral
rickettsiae are the favorite candidate for the endosymbiote
that led to mitochondria [2], and mitochondria possess a
functionally similar system (mitochondrial ADP/ATP carrier
or AAC) that transports mitochondrial ATP in exchange for
cytosolic ADP [3], the physiological direction of ATP
transport in these two systems is opposite [4]. Recently, a
homologous ATP/ADP transporter was described in another
obligate intracellular bacterium Chlamydia trachomatis
[5,6] and, in addition, several members of the Tlc family
were found in plant plastids [7–9]. To date, more than 16
members of the Tlc family of membrane transporters are
known. The members of the family with known functions
are involved in the transport of various ribonucleotides.
The functional similarity notwithstanding, mitochondrial
and non-mitochondrial ATP transporters are quite dissimilar
biochemically and structurally. Tlc and AAC share no sig-
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nificant homology at the nucleotide or amino acid levels. Tlc
is insensitive [1,10] to carboxyatractyloside and bongkrekic
acid, which are specific inhibitors of AAC [11–13]. Mito-
chondrial transporters are believed to function as homo-
dimers and mitochondrial ATP carriers have an internal
sequence homology indicative of a gene triplication of a
common ancestor coding for a protein of about 100 amino
acids [14,15], features not observed in Tlc family of proteins.
The topological model of Tlc generated by antibody acces-
sibility [16] and the dual reporter approach [17,18] suggests
that Tlc polypeptide crosses the cytoplasmic membrane 12
times, with its N- and C-termini facing the cytoplasm,
whereas AAC monomer spans membrane six times [19].
Despite many differences, mitochondrial and non-mito-
chondrial ATP transporters share one common feature: they
all are very basic proteins with isoelectric points (pI’s)
between 9.24 and 9.98. This suggests that electrostatic forces
might be important for Tlc–substrate interactions. Alterna-
tively, positively charged amino acid residues could be
involved in shielding of negative charges on substrates
(ATP and ADP) during translocation through hydrophobic
membrane environment. However, to date, only 12 out of 43
positively charged residues were mutated in AAC [19–21]
and only two positively charged residues were mutated in
ATP/ADP transporter from Arabidopsis [22]. Therefore, this
study was undertaken as the first systematic attempt to mutate
all positively charged residues in any ATP/ADP transporter.
2. Materials and methods
2.1. Site-directed mutagenesis
Site-directed mutagenesis was performed essentially as
described earlier [23], except reactions were scaled-up two-
fold and VentR DNA polymerase was used instead of Pwo.
In several instances, a modified restriction site PCR [24] and
overlap-extension PCR [25] were used to introduce muta-
tions. First, the two Cys residues found in wild-type (WT) tlc
protein were replaced with Ala in the cassette version of the
synthetic WT tlc gene [26] using primers 68-3V TT-
CCTGTTTCAGGATGTCGGCCAGTTTAACG and 68-5V
TTCATGATGTTCGCCATCCTGCTGAACTAC. The Cys-
less protein had been shown to have WT activity [27]. The
resulting Cys-less synthetic cassette tlc gene was eventually
cloned in a pET11a derivative thus generating pMA619 and
used as a template in all subsequent mutagenesis reactions.
pMA619 (Fig. 1) represents a pET11a derivative with the
synthetic C-less tlc gene cloned between NdeI and BamHI
sites. The pET11a backbone in pMA619 was modified to
remove a PstI site from the bla gene and to introduce a
polylinker. The overall strategy included mutagenesis of
short (350–550 bp) fragments of the gene with subsequent
substitution of the WT fragment in pMA619 with the
corresponding mutated one using appropriate restriction
enzyme sites found in synthetic gene. Multiple mutations
in Tlc were generated by combining single mutations in one
molecule by subcloning corresponding fragments of single
mutants, by doing sequential rounds of mutagenesis, or by
designing primers with multiple mutations.
2.2. Transport activity assays
Activity of Tlc mutants was evaluated in Escherichia coli
C41 cells [28] upon induction with isopropyl-h-D-thioga-
lactopyranoside (IPTG) essentially as described previously
[26]. Protein content of the samples was determined using
BC reagent kit (BioRad) according to the manufacturer’s
recommendations and ATP transport rates were expressed as
picomoles ATP (milligram protein)1.
2.3. Reactions with MTS compounds
The effect of MTS compounds was determined after
pretreatment of the cells with 0.78 mM 2-aminoethyl meth-
anethiosulfonate hydrobromide (MTSEA), 2.5 mM [2-(tri-
methylammonium)ethyl] methanethiosulfonate bromide
(MTSET) or 1 mM sodium(2-sulfonatoethyl)methanethio-
sulfonate (MTSES) for 5 min in KPi buffer before ATP
uptake measurements. The compounds were prepared as
10stocks in water immediately before use. Control sam-
ples were treated with water for the same period of time.
2.4. Cytoplasmic membrane preparations
E. coli cells were grown in 250-ml baffled-bottom flasks
containing 50ml ofmedium, induced as described above, and
collected by centrifugation at 5000g for 15 min at 4 jC. The
cell pellet was resuspended in 1 ml KPi buffer containing 1
mM phenylmethylsulfonyl fluoride (PMSF) and protease in-
hibitor cocktail and disrupted by sonication for 1 min. Un-
broken cells and cell debris were removed by centrifugation
at 10,000g for 15min at 4 jC. Themembranes were then se-
dimented by centrifugation at 150,000g for 45 min at 4 jC.
Fig. 1. The map of pMA619. Only relevant unique restriction sites are
shown. bla, ampicillin-resistance gene; T7 term, T7 phage terminator; lacI,
the gene for lac repressor, pMB1ori, origin of replication.
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2.5. Western blotting
Purified cytoplasmic membranes were resuspended in
water, adjusted to the same total protein concentration and
solubilized in SDS-PAGE buffer. Electrophoretic separation
of proteins was performed using Tris–Tricine buffer system
(Amersham-Pharmacia Biotech). Proteins were transferred
to PVDF membranes in a carbonate–bicarbonate buffer
system [13], blocked in 5% non-fat dry milk or 3% BSA
for 30 min and probed with antibodies developed against
peptide corresponding to C-terminal portion of Tlc [16].
Western blots were developed with BCIP substrate (KPL)
after incubation with goat anti-rabbit IgG conjugated to
alkaline phosphatase (Sigma).
3. Results and discussion
3.1. Properties of single mutants
Every positively charged residue in R. prowazekii Tlc was
individually mutated to Cys, thus generating a set of 51
single-Cys mutants. The transport activity in the resulting
mutants varied between nearly 0 and more than 200% (Table
1). No major differences in Tlc expression levels could be
detected by Western blotting (results not shown). Overall,
mutation of only 20 out of 51 basic residues resulted in
severe (>80%) inhibition of transport activity. According to
the existing topological model [18], basic amino acid resi-
dues in Tlc are distributed asymmetrically (33 residues in
cytoplasmic domains, 15 residues in periplasmic domains
and 3 residues in transmembrane regions), which is consis-
tent with ‘‘positive inside’’ rule [29]. However, asymmetry
of distribution of the essential residues (>80% inhibition)
between cytoplasmic and periplasmic compartments is less
pronounced (11 residues in cytoplasmic domains, 7 residues
in periplasmic domains and 2 residues in transmembrane
regions). This might be a reflection of the symmetrical nature
of transport conducted by Tlc.
Interestingly, in 12 cases (11 Lys residues and 1 Arg
residue), replacements resulted in proteins that had higher
transport activities as compared to WT (up-mutations). With
two exceptions, those residues (up-residues) are located in
cytoplasmic loops. Of the exceptions, one residue (Lys306)
is located in periplasmic loop 8 and another (Lys483) in
transmembrane helix 12, close to cytoplasmic face (Fig. 2).
Up-residues are clustered in the two largest cytoplasmic
loops 7 and 11 (four and three mutations, respectively).
Table 1
Properties of single mutants
Mutant Locationa Conservationb Percentage activityc Mutant Locationa Conservationb Percentage activityc
K5C Cyto1 25(25) 65F19 (6) K257C Cyto7 81(81) 120F38 (7)
R14C Cyto1 50(56) 55F11 (6) K259C Cyto7 19(25) 170F8 (3)
K15C Cyto1 13(19) 52F7 (5) K260C Cyto7 88(100) 142F61 (6)
K26C Cyto1 63(63) 6F2 (6) K262C Cyto7 75(81) 145F34 (6)
K27C Cyto1 88(88) 36F10 (5) K264C Cyto7 75(81) 89F10 (6)
R46C Tm1 81(94) 7F1 (3) K272C Cyto7 50(50) 54F25 (5)
K49C Peri2 94(100) 6F1 (3) K278C Cyto7 25(63) 19F13 (7)
K66C Tm2 100(100) 4F1 (4) K302C Peri8 88(88) 3F1 (5)
K83C Cyto3 81(88) 9F1 (4) K304C Peri8 63(63) 24F4 (3)
K89C Cyto3 19(19) 49F6 (4) K306C Peri8 75(75) 142F31 (11)
H120 Peri4 88(88) 5F1 (2) K312C Peri8 13(25) 20F13 (6)
H123 Peri4 6(13) 51F1 (2) R342C Cyto9 81(88) 13F2 (3)
K124C Peri4 6(6) 37F3 (3) K343C Cyto9 50(75) 48F16 (6)
K137C Peri4 44(56) 12F2 (7) K402C Cyto11 81(94) 7F2 (6)
K141C Peri4 13(19) 24F3 (4) K405C Cyto11 94(94) 5F1 (3)
K145C Peri4 25(25) 58F22 (6) K413C Cyto11 88(94) 9F1 (4)
K176C Cyto5 31(31) 215F52 (8) K422C Cyto11 13(13) 251F96 (10)
K181C Cyto5 81(81) 19F7 (6) R425C Cyto11 19(100) 196F77 (9)
R182C Cyto5 75(94) 14F4 (3) K427C Cyto11 81(88) 333F121 (9)
H207 Peri6 13(31) 24F9 (2) R438C Cyto11 44(69) 6F2 (6)
K209C Peri6 19(19) 7F1 (3) K441C Cyto11 100(100) 9F5 (6)
H216 Peri6 25(25) 11F7 (2) K483C Tm12 44(63) 113F6 (3)
K218C Peri6 13(13) 6F1 (3) K487C Cyto13 50(63) 95F39 (6)
R238C Cyto7 31(38) 31F15 (8) K495C Cyto13 25(38) 242F97(6)
K242C Cyto7 50(94) 48F18 (7) K498C Cyto13 19(19) 153F39 (7)
R249C Cyto7 25(38) 51F13 (6)
a Location of the mutated residue relative to the cytoplasmic membrane. Cyto, cytoplasmic; Tm, transmembrane; Peri, periplasmic. The numbers indicate
the consecutive numbers of the corresponding domains.
b Conservation of corresponding residues based on alignment of 16 Tlc homologs. The first number indicates percentage identity, the number in
parentheses indicates percentage similarity.
c Residual activity of corresponding single mutants expressed as meanFS.D. The number in parentheses indicates the number of independent experiments
used to generate data.
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Loops 7 and 11, which have 10 and 8 positively charged
residues, seem to differ with respect to their tolerance of the
replacements of positively charged residues with cysteines.
Interestingly, in a previous study, we have found that
insertions of short (25aa and 42aa) amino acid sequences
are tolerated by loop 7, but not by loop 11 [17]. It appears
that, with one exception, each of loop 7 mutants retains at
least 30% of WT activity, suggesting that 9 of 10 positive
charges in this loop are dispensable for function. On the
other hand, residues in loop 11 are much less tolerant to
replacements and, with exception of up-residues, mutants
retain less than 10% of WT activity under similar condi-
tions.
The residual activity of the mutants poorly correlates with
charge conservation based on the alignment of 16 Tlc
homologs (Table 1). One might expect high residual activity
when conservation is poor and low activity when conserva-
tion is high. However, 33% (17 out of 51) of mutants
demonstrate residual activity inconsistent with charge con-
servation at corresponding positions. For example, despite
poor conservation of basic residues at positions 209 (19%)
and 218 (13%) in periplasmic loop 6, the residual activity of
corresponding mutants is relatively low (7% and 18% ofWT,
correspondingly). Conversely, Cys replacement mutants of
better than 50% conserved positively charged residues at
positions 14, 27, 242, 257, 260, 262, 264, 278, 304, 306,
343, 425, 427, 483 and 487 have fairly high residual activity
(43%, 31%, 60%, 153%, 210%, 182%, 88%, 30%, 26%,
150%, 54%, 183%, 349%, 115% and 48% of WT, respec-
tively). Interestingly, 7 of 12 up-residues (Lys257, 260, 262,
306, 427, 483 and Arg425) are located at positions with good
charge conservation (81%, 100%, 81%, 75%, 88%, 63% and
100%, respectively). Also, a significant fraction (two of five)
of Cys-replacement mutants at positions with 100% con-
served positive charges retained more than 100% of WT
activity, which is inconsistent with the initial hypothesis
about significance of positive charges.
3.2. Effect of multiple replacements of positively charged
residues
To get further insight into the role of Lys and Arg residues
whose replacement with cysteins results in up-mutations, we
constructed several additional mutations involving these
residues (Lys422, Arg425 and Lys427) in loop 11 (Fig. 3).
First, all possible double mutants of three up-residues in loop
11 were constructed (Fig. 3a). A double Lys422Cys
Lys427Cys mutant in loop 11 exhibited transport rate that
was almost equal to a sum of activities of corresponding
single mutants and more than five-fold exceeded that of WT
protein. The transport activities of other two double mutants
were still higher than that found in WT control. An additive
behavior of double Lys422Cys Lys427Cys mutant strongly
suggests functional dispensability of Lys422 and Lys427 and
suggests that these two mutations might affect different
aspects of the transport process. Kinetic studies performed
on mutants have shown that Km in mutants Lys422Cys,
Lys427Cys, and Lys422Cys Lys427Cys remained similar to
those of WT protein (Fig. 4). This suggests that differences
in transport rates are attributable primarily to changes in
Vmax. This also suggests that above residues are more
involved in the translocation process than in the binding of
negatively charged substrates. Therefore, it appears that Tlc
has evolved a mechanism that limits the transporter’s
exchange rate and that Lys422 and Lys427 are playing a
key role in that mechanism. Further, we reversed charges at
the positions 422, 425 and 427 in Tlc by replacing positively
charged residues with glutamate (Fig. 3b). The transport rate
of K422E was higher than in WT and R425E did not change
compared to WT, while the transport rate of K427E mutant
Fig. 2. Positioning of the mutated basic residues on the topological map of Tlc. Open circles, open squares and solid squares designate residues, whose
replacement with Cys is inhibitory (<20% of WT activity), neutral (20–100% residual activity) and stimulatory (>100% activity).
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was inhibited (but 28% of WT activity remained). This again
supports the idea of dispensability of positive charges at
positions 422, 425 and 427.
Individual and multiple mutations of Arg and Lys residues
in loop 11 suggested that at least some positively charged
residues are non-essential for function. To strengthen this
suggestion, we investigated how well multiple replacements
are tolerated by Tlc. Thus, a mutant was constructed in which
five clustered Lys residues in loop7 (Lys257, 259, 260, 262
and 264) were replaced with Cys. Interestingly, this quintuple
mutant still retained about 20% of WT activity (Table 2).
Therefore, this cluster mutation was combined with other
mutations taking advantage of unique restriction endonu-
clease sites found in the synthetic tlc gene [26]. Introduction
of Lys306Cys up-mutation into this quintuple mutant resulted
in a protein with about three-fold increase in transport rate.
Mutating two more residues in the resulting hextuple mutant
(Lys15Cys and Lys176Cys or Lys422Cys and Lys427Cys
mutations) reduced transport rates to about 30% of WT. A
mutant with 10 positively charged residues replaced with Cys
still retained 9% of WT activity, while replacement of 11
positively charged residues reduced activity to essentially
background level (Table 2). This all strongly suggested
dispensability of at least some positively charged residues
in Tlc.
3.3. Potential involvement of Lys and Arg residues in
formation of interhelical charge pairs
Charged residues are rarely found in transmembrane
domains (TMs) of proteins because of the high free energy
that such residues possess in hydrophobic environment. At
least in some instances membrane proteins have been shown
to minimize this energy through formation of interhelical
charge pairs (salt bridges). Thus, two such bridges (between
Asp237 and Lys358 and between Asp240 and Lys319) were
identified in lactose permease (LacY) of E. coli. These
bridges were initially identified through second site sup-
pressor analysis [30,31] and later confirmed by biochemical
techniques [32–34]. Remarkably, it was noticed that
replacement of one member of a charged pair with a residue
with a neutral side chain led to inactivation of the permease,
whereas mutants in which neutral amino acids replaced both
charged residues retained activity. Similarly, simultaneous
charge reversal at both positions has been shown in some
instances to produce an active protein, whereas the corre-
sponding single mutants were inactive [34].
According to the current topological model [18], Tlc has
three intramembrane positive charges, Arg46 (TM I), Lys66
(TM II) and Lys483 (TM XII), and only one intramembrane
negative charge, Glu156 (TM IV). Of those three intramem-
brane positive charges, neutralization of only two (Arg46 and
Lys66) led to loss of activity. It is currently impossible to
identify charge pairs in Tlc by either second site suppressor
analysis or by chemical cross-linking experiments because of
the absence of a system that would allow for selection of Tlc
function and because of the absence of sites to produce
functional ‘‘split’’ translocases, respectively. Therefore, we
constructed single Glu156Cys, Glu156Lys, Arg46Glu, and
Lys66Glu as well as double Arg46Cys Glu156Cys,
Lys66Cys Glu156Cys, Arg46Glu Glu156Lys, and Lys66Glu
Glu156Lys mutants and tested if their behavior fits that
expected of residues involved in the formation of charge
pairs. All newly constructed single mutants were inactive,
which would be expected of mutants of charge pair forming
residues. However, the gain of function was not observed
with any of the double mutants tested suggesting that Arg46,
Lys66 and Glu156 may be involved in the formation of
charge pairs with residues other than themselves (data not
shown). Similar situation is observed in yeast AAC carrier,
which has four positively charged residues in the transmem-
Fig. 3. Effect of replacements of up-residues in loop 11 on Tlc activity.
(Panel a) Activities of double Cys-replacement mutants. (Panel b) Activities
of the charge inversion mutants. Under each panel, a Western blot of
membrane preparations from respective mutants is shown to demonstrate
that steady-state Tlc levels were unchanged.
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brane helices. In that case, second-site suppressor analysis
revealed that transmembrane positive charges are paired with
extramembrane negative counterparts [35].
3.4. Effect of MTS compounds on the activity of single Cys
replacement mutants
One of the advantages of Cys replacement mutagenesis is
the availability of a battery of Cys-specific reagents that can
be used for modification of the introduced Cys residues. This
combination of Cys-scanning mutagenesis and subsequent
modification with such reagents has been successfully used
to elucidate membrane topology, spatial proximity between
TMs and to identify intramembrane residues involved in
formation of ‘‘water-filled channels’’ for substrate trans-
location (reviewed in Ref. [36]). We studied the effect of
treatment with two membrane-impermeable sulfhydryl-spe-
cific reagents, MTSET and MTSES [37], on all 51 single
Cys-replacement mutants. The modification of the cysteine’s
SH group with MTSET reintroduces the positive charge and
modification with MTSES reverses the WTcharge. With one
exception, treatment with these MTS compounds had no
effect on mutants. This is expected with Cys that are located
in cytoplasmic loops and therefore inaccessible to modifica-
tion. Treatment of only 1 of 15 mutants with predicted
periplasmic localization affected activity. Although our
experimental setup does not allow one to exclude the
possibility that the other 14 periplasmic cysteins are inacces-
sible to modification, this seems unlikely. Modification of
Lys306Cys with MTSET reduced the ATP transport to
28F5% of untreated control, whereas MTSES treatment
reduced it to 11F1%. The more severe effect of MTSES
treatment on Lys306Cys is consistent with charge reversal by
site-directed mutagenesis (2.5% of WT activity in Lys306-
Glu mutant vs. 285% in Lys306Arg mutant, data not shown).
The inhibitory effect of MTSET as compared to the
Lys306Arg mutation apparently results from the bulkiness
of the formed adduct. Interestingly, ATP does not protect the
Lys306Cys mutant from MTSES modification, which sug-
gests that Lys306 does not directly interact with the sub-
strate.
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Fig. 4. Comparison of kinetics of ATP transport. The E. coli cells expressing the WT Tlc and mutants were grown, induced, washed and the kinetics determined
in at least two independent experiments at 34 jC with triplicate points at 1 min for each substrate concentration. Non-linear regression analysis was based on
the Michaelis–Menten equation and computed with the help of GraphPad Prism software.
Table 2
Properties of multiple Cys-replacement Tlc mutants
Mutated residues Number of
residues
mutateda
Residual activity
of the mutant
(number of experiments)b
257, 259, 260, 262, 264 5 20F5 (5)
257, 259, 260, 262, 264, 306 6 64F15 (6)
15, 176, 257, 259, 260,
262, 264, 306
8 28F9 (6)
257, 259, 260, 262, 264,
306, 422, 427
8 34F9 (4)
15, 176, 257, 259, 260,
262, 264, 306, 422, 427
10 9F3 (6)
15, 176, 257, 259, 260, 262,
264, 306, 422, 425, 427
11 3F1 (6)
a The total number of positively charged residues replaced in each
multiple mutant.
b Percentage activity remaining in the multiple mutant as compared to
WT. Numbers are meanFS.D. The number of independent experiments
used to generate the data is given in parentheses.
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